ABSTRACT: Nitric Oxide (NO) can be cytotoxic or cytoprotective depending on amount and location of its generation. eNOS is important in modulating blood flow and is allosterically regulated. Inducible NOS (iNOS) tends to produce large quantities of NO leading to cell injury. We studied the role and regulation of NOS in carbon tetrachloride (CCl 4 )-induced hepatotoxicity in newborn rats. eNOS was expressed before birth, significantly increased on day of life (DOL) 2 reaching a maximum at DOL-20. iNOS was absent at all ages. CCl 4 treatment resulted in hepatic injury in newborn rats and damage was intensified by co-administration of a general NOS inhibitor. CCl 4 treatment increased eNOS activity without change in mRNA or protein levels. Administration of CCl 4 resulted in an increase in phosphorylation of threonine protein kinase (Akt) and eNOS, associated with an increase in eNOS activity. Administration of wortmannin (phosphatidylinositol 3-kinase, PI3 K, inhibitor) attenuated the phosphorylation of Akt and eNOS and reduced eNOS activity. Co-administration of CCl 4 and wortmannin potentiated the degree of hepatic injury. iNOS was not detectable in CCl 4 -treated rats. This data indicates a protective role for eNOS in D ifferences exist in the response to toxic hepatic injury in neonates compared with adults. Previous studies have indicated that immature liver is partially protected from carbon tetrachloride (CCl 4 )-induced injury (1-3); proposed mechanisms include an underdeveloped cytochrome P-450 system and increased stimulation of hepatocellular regeneration and tissue repair mechanisms (1,4). Newer evidence shows that acute CCl 4 toxicity increases nitric oxide synthase (NOS) activity resulting in increased hepatic blood flow, both in the portal vein and hepatic artery (5,6). Co-administration of CCl 4 and NOS inhibitors dampens increased hepatic artery blood flow, worsening of hepatocellular damage (5,6), suggesting a protective role for NOS in this model via increased hepatic artery blood flow.
D
ifferences exist in the response to toxic hepatic injury in neonates compared with adults. Previous studies have indicated that immature liver is partially protected from carbon tetrachloride (CCl 4 )-induced injury (1-3); proposed mechanisms include an underdeveloped cytochrome P-450 system and increased stimulation of hepatocellular regeneration and tissue repair mechanisms (1, 4) . Newer evidence shows that acute CCl 4 toxicity increases nitric oxide synthase (NOS) activity resulting in increased hepatic blood flow, both in the portal vein and hepatic artery (5, 6) . Co-administration of CCl 4 and NOS inhibitors dampens increased hepatic artery blood flow, worsening of hepatocellular damage (5, 6) , suggesting a protective role for NOS in this model via increased hepatic artery blood flow.
Hepatic blood flow in neonates differs from adults by nature of a ductus venosus, which shunts blood away from hepatocytes. There are also maturational differences in hepatic blood flow regulation; the hepatic artery contributes more to maintenance of sinusoidal blood flow in the immature liver than in the adult liver (7) . Normally, hepatic blood flow is under the control of eNOS present in sinusoidal endothelial cells (8) . Moreover, there is developmental expression of NOS in the liver. eNOS is minimally expressed in the prenatal liver, increases rapidly after birth, and reaches a maximum at 20 d of life, which is maintained in adults (9) . Hepatic iNOS activity is not detectable during normal development (9) .
Nitric oxide (NO) plays important roles in the liver with potential for being both cytotoxic and cytoprotective. Factors in determining beneficial versus harmful effects include location, amount, and duration of NO generation. eNOS is constitutively expressed in the endothelium of most tissues, playing an important role in regulating blood flow in response to hemodynamic shear stress and endothelial-dependent vasodilators. NO generated by eNOS is allosterically regulated and in small amounts leads to vasodilation. Unlike eNOS, iNOS is inducible and present in most liver cells. iNOS lacks fine regulation and tends to produce large quantities of NO once induced. Excessive NO leads to cell injury through nitrosylation of cellular enzymes and potentiation of oxidative stress by forming peroxynitrite (reviewed in Ref. 10) . Normally only eNOS is present in the liver, whereas hepatic iNOS is upregulated by a number of conditions (endotoxemia, hemorrhagic shock, sepsis, ischemia-reperfusion, and liver regeneration). NO has been shown to protect against oxidative damage and peroxidation induced by experimental models such as alcohol (11), H 2 O 2 -mediated oxidative stress (12) , and CCl 4 (13) .
The regulation and roles of eNOS and iNOS in CCl 4 -induced hepatotoxicity have not been elucidated in the developing liver. We performed this study to determine what role age-related differences in NOS expression plays in acute CCl 4 -induced hepatocellular injury.
METHODS

Chemicals.
Unless otherwise stated, all chemicals in this study were purchased from Sigma Chemical Co. (St. Louis, MO). Antibodies for Western blot were purchased as follows: anti-eNOS and anti-iNOS from BD Biosciences (San Diego, CA), antiactin from Chemicon (Temecula, CA), antiphospho-eNOS, antiserine/threonine protein kinase (Akt), antiphospho-Akt, and wortmannin (a phosphatidylinositol 3-kinase, PI3 K, inhibitor) were purchased from Cell Signaling (Danvers, MA).
Animal treatment. Pregnant Sprague-Dawley rats were obtained at 14 d of gestation and kept in plastic cages with free access to food and water with alternating 12-h periods of light and darkness. In experiments requiring fetal tissue, the dam was killed by CO 2 narcosis and cervical dislocation, followed by delivery of fetuses by cesarean section. In age-related experiments, newborn rats were kept with the mother with free access to breast-feeding before weaning, and standard rat chow and water post weaning. The age of rats studied were day of life (DOL) 0, 2, 5, 10, and 20. Adult, male SpragueDawley rats (200 -250 g) were used as the adult time point, to avoid any potential effect of estrous on NOS expression. In the study of CCl 4 -induced hepatotoxicity, pups of either sex from various litters of equal postnatal age were randomized to one of the three experimental groups: 1) control group (vehicle, corn oil), 2) CCl 4 [100 L/kg body weight (BW), i. Evaluation of CCl 4 hepatotoxicity. Blood samples were collected and centrifuged at room temperature for 10 min at 13,000 rpm. Serum was assayed for alanine aminotransferase (ALT) activity following the protocol of an ALT assay kit (Sigma Chemical Co. Diagnostics, St. Louis, MO). Liver samples from each aged animal were fixed in 10% formalin, paraffin-embedded, and sections obtained and stained with hemotoxylin and eosin for histologic evaluation.
Determination of lipid peroxidation. Tissue concentration of malondialdehyde (MDA), an intermediate of lipid peroxidation, was measured as described previously (14) .
Real time RT-PCR for NOS. cDNA was synthesized using iScript cDNA Synthesis system (Bio-Rad Hercules, CA) on total cellular RNA. Controls without reverse transcriptase were performed for each sample to ensure absence of genomic DNA. Real time PCR was carried out in a real time thermal cycler (iCycler, Bio-Rad) using iQ SYBR Green Supermix (BioRad). Cycling conditions were 5 min at 95°C, followed by 40 cycles of 15 s at 95°C, 15 s at 55°C, then 60 s at 72°C. PCR specificity was tested via analysis of the melting curve and agarose gel electrophoresis. To semiquantify input amounts of templates, standard curves were constructed with serial dilutions of cDNA sample from a positive control (brain tissue from lipopolysaccharide-treated rat). To standardize results, interpolated values for each sample were divided by the value of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Primers were designed with Primer3 software (15) and checked for absence of crossreactivity by BLAST search. The primer pairs used, product size, and positive controls are shown in Table 1 .
Western blotting for eNOS, iNOS, and Akt. Liver tissue was homogenized in 50 mM HEPES, pH 7.4, 1 mM EDTA and protease inhibitor cocktail, followed by centrifugation at 15,000g for 30 min. Protein was separated by 7.5% SDS-PAGE, transferred to nitrocellulose membranes, and visualized by Enhanced Chemiluminescence System (Amersham Health). Densitometric quantification of Western blot signal intensity of autoradiograms was performed using a Molecular Dynamics P.D densitometer.
Measurement of eNOS and iNOS activity. NOS activity was estimated by formation of nitrite/nitrate from L-arginine through the in vitro reaction of NOS, according to the method described by Kelley et al. (16) . Nitrite/ nitrate generated in the reaction mixture by NOS activity was measured with a Nitric Oxide Synthase Assay kit (Calbiochem, San Diego, CA). An eNOS inhibitor L-N (5)-(1-iminoethyl)-ornithine (L-NIO) at final concentration of 10 M in the reaction mixture was used in a separate set of eNOS activity assays to confirm eNOS specific activity.
Statistical analysis. Values are expressed as mean Ϯ SE (SEM). Statistical analysis was performed using unpaired t test (for only two groups) and analysis of variance (for more than two groups). Statistical significance was considered at p Ͻ 0.05.
RESULTS
Age related eNOS and iNOS expression.
Ontogeny of hepatic eNOS, as determined by western blot analysis and activity ( Fig. 1A and B) , was similar to our previous study (9) . eNOS was presented before birth, albeit at low levels. On DOL-2 eNOS protein and activity were significantly increased compared with earlier times. There was further increase until a maximum was attained at DOL-20, which persisted in the adult. NOS mRNA was determined by real time RT-PCR. Validation of the PCR and primers was performed by serial dilution of cDNA. The coefficiency of the PCR was Ͼ0.995 and the efficiency of the PCR was 100 Ϯ 10%. eNOS mRNA showed a pattern similar to its protein expression, with the exception of a relatively lower level of expression in the adult (Fig. 1C) . iNOS mRNA, protein, and activity were undetectable at all ages.
Hepatic damage due to CCl 4 . Hepatic injury, measured by serum ALT, was noted in all ages (DOL-0 to DOL-20, Fig.  2A ). ALT increase was mild; about 3-fold over control values. Co-administration of CCl 4 and the nonselective NOS inhibitor L-NAME increased hepatic damage compared with CCl 4 alone starting on DOL-2 ( Fig. 2A) . Administration of L-NAME alone had no effect on ALT (16.69 Ϯ 3.88 U/mL). Histologic examination showed typical features of CCl 4 toxicity from DOL-2 to adult ( Fig. 3C and D) , such as ballooning degeneration with pycnotic nuclei and individual hepatocyte necrosis; fibrosis was not seen. In adults, the findings were most pronounced in zone 3 (central vein), with some involvement of zone 2. In less mature animals, histologic features were found throughout the hepatic lobule, although with a prominence in zone 3. Animals exposed to CCl 4 on DOL-0 had minimal evidence of injury, limited to scattered necrotic hepatocytes (Fig. 3B) .
Determination of lipid peroxidation. Determination of MDA showed an increase in lipid peroxidation following administration of CCl 4 (Fig. 2B) . Simultaneous administration of the CCl 4 and L-NAME had no effect on the degree of lipid peroxidation compared with CCl 4 treatment alone.
NOS expression during CCl 4 hepatotoxicity. eNOS and iNOS mRNA was determined by real time PCR and expressed as a ratio to GAPDH. Administration of CCl 4 with or without L-NAME had no effect on eNOS expression (Fig. 4A) . iNOS mRNA was not detected in any animal. eNOS and iNOS proteins were determined by Western blot analysis using actin as the constitutively expressed protein. Similar to mRNA, administration of CCl 4 with or without L-NAME had no effect on eNOS protein expression (Fig. 4B) . iNOS protein was not detected in any animal (Fig. 4D ). CCl 4 administration had no effect on eNOS activity on DOL-0; however, eNOS activity increased significantly at all ages beginning on DOL-2. Coadministration of CCl 4 and L-NAME had no effect on eNOS activity on DOL-0, but decreased activity below control levels in all ages from DOL-2 (Fig. 4C) . iNOS activity was not detected under any conditions.
Posttranslational regulation of eNOS. There is a disconnect between eNOS expression and activity in CCl 4 -induced hepatotoxicity. Evidence indicates that eNOS activity can be activated by posttranslational modification mediated by phosphorylation of eNOS through the PI3k/Akt signaling pathway (17, 18) . We examined posttranslational regulation of eNOS in our experimental model. CCl 4 treatment resulted in increased phosphorylation of both Akt and eNOS (the active forms of Akt and eNOS, respectively) as determined by western blot analysis ( Fig. 5A and B) . Increased phosphorylation of eNOS was associated with increased eNOS activity (Fig. 6A) . Treatment with wortmannin (inhibitor of PI3 K/Akt signaling) reduced eNOS activity below control values. Similarly, increased eNOS activity seen with CCl 4 administration was negated by coadministration of wortmannin and CCl 4 (Fig. 6A) . Western blot analysis showed that wortmannin attenuated phosphorylation of Akt and eNOS both in control and CCl 4 -treated rats (Fig.  5A and B) . Co-administration of CCl 4 and wortmannin potentiated the degree of hepatic injury compared with CCl 4 alone; wortmannin alone did not cause hepatic injury (Fig. 6B) .
DISCUSSION
The role of NOS in hepatic disease is complicated. The effect of NOS, mediated through production of NO, has variable, and sometimes, contradictory effects. NO can protect the liver by scavenging lipid radicals and inhibiting the lipid peroxidation chain reaction (13) . Alternatively, hydroxyl radicals formed by the reaction of NO and superoxide anion via peroxynitrate may result in hepatotoxicity (10) . NO is also important in regulating hepatic blood flow, with an indirect effect on hepatocellular injury (6) . In this study, we sought to characterize the role of NOS in CCl 4 -induced hepatotoxicity in the developing liver.
Our data shows that administration of CCl 4 leads to mild increase in serum ALT in the newborn rat consistent with previous studies (1-3) . Administration of CCl 4 led to an increase in hepatic eNOS activity with no detectable iNOS activity. These findings are in contrast to some studies showing induction of iNOS in adult rats following exposure to CCl 4 (6, 13, 19) , but in agreement with other studies showing exposure to CCl 4 results in eNOS activation (20) without upregulation of iNOS (21, 22) . In this study, co-administration of CCl 4 and L-NAME led to a worsening of hepatic injury, suggesting a protective role for eNOS in CCl 4 -induced toxicity.
Studies have shown that newborn rat is "resilient" to CCl 4 toxicity (1,3,4) based on serum ALT levels and lethality compared with adult rats. Resiliency has been explained by undeveloped cytochrome P450, increased hepatocellular growth, and tissue repair mechanisms in young rats (1, 4) . Yet, in our study, histopathological changes were present in all animals. These data are consistent with a previous study, where livers from DOL-1 rats were minimally damaged by CCl 4 compared with rats at DOL-4, 10, 14, 21, and adults (23) . CCl 4 is bioactivated by cytochrome P450 to free radicals. The major isozyme for the process is cytochrome P450 2E1 (24) . Ontogeny studies have demonstrated that cytochrome P450 2E1 protein is not detectable in the liver of DOL-1 rat; starts to increase rapidly on DOL-3; and reaches approximately 50% of adult levels on DOL-28 (25) . The ontogeny of cytochrome P450 2E1 is mirrored by hepatic damage in our and previous studies (23) , where no significant histologic alterations are seen at DOL-0 and DOL-1 but similar histologic damage is seen regardless of age after DOL-2. Lower serum ALT in CCl 4 -treated newborn rats does not indicate less hepatic injury compared with adult rats. Rather, the lower serum ALT in newborns could be simply because of less availability of the hepatic enzyme to leak into the blood stream during CCl 4 toxicity. Supporting evidence comes from a previous study showing that hepatocellular ALT content is significantly lower in newborn than in adult rats (26) .
Previous studies report mixed results when assessing inhibition of NOS in CCl 4 -induced hepatotoxicity, particularly the effect on peroxidation. Administration of a nonselective NOSinhibitor (L-NAME) increases lipid peroxidation following exposure to CCl 4 , suggesting NO plays a protective role in CCl 4 intoxication through interaction with reactive oxygen species (ROS) (13) . Conversely, a selective iNOS inhibitor (L-NIL) inhibited peroxidation following CCl 4 administration suggesting that NO plays a deleterious role in CCl 4 intoxication in adult rats (19) . We measured hepatic tissue MDA following CCl 4 exposure showing that, while lipid peroxidation occurs, it is not altered by co-administration of CCl 4 and L-NAME despite increased hepatic injury. This data would suggest that in this model NO does not participate in lipid peroxidation through interaction with ROS or lipid peroxyl groups.
An alternative explanation is that eNOS offers protection from acute CCl 4 -induced toxicity by a mechanism unrelated to ROS production, such as changes in hepatic blood flow. Previous data have shown that acute CCl 4 toxicity results in increased hepatic blood flow, both in the portal vein and hepatic artery (5, 6) . Increase in hepatic artery blood flow is mediated by increased NO production via up-regulation of NOS, resulting in reduced hepatic damage. Inhibition of NOS activity dampens hepatic artery flow exacerbating hepatic damage (6) . NO has also been shown to improve hepatic microvascular perfusion through reducing neutrophil accumulation and platelet aggregation (27) . Beneficial effects of increased hepatic blood flow in CCl 4 -induced injury may be related to improved oxygen delivery to the damaged liver (6) . Inflammation results in increased arterial blood flow due to increased oxygen demand for synthesis of DNA and proteins needed for tissue repair in hepatic regeneration (28) . In CCl 4 toxicity, increased hepatic arterial blood flow provides greater oxygen supply to promote liver regeneration following acute hepatic injury (6) . Although the exact protective mechanism afforded against CCl 4 toxicity by increased hepatic artery blood flow remains to be determined, further study on hepatic hemodynamic changes in CCl 4 toxicity will strengthen the current findings.
The principle control of hepatic blood flow under normal conditions is at the level of the sinusoid and is mediated by eNOS (8) . In newborn rats, eNOS mRNA, protein, and activity increase in parallel reaching adult levels by 20 d of life (9) . Immunohistochemical staining reveals that eNOS is present in the sinusoids at birth, albeit in low amounts and scattered across the lobule. Sinusoidal eNOS increases in intensity and distribution with age, reaching an adult pattern by 20 d of life (9) . There is also data showing that the hepatic artery contributes more to sinusoidal blood flow maintenance in the immature liver than in the adult liver (7) . At baseline, the hepatic artery is under the control of NOS. Supportive evidence includes vasoconstriction, and resulting increased hepatic artery resistance, following inhibition of NOS by L-NAME and partial reversal of vasoconstriction following administration of L-arginine (29) . These findings may help explain why, despite paucity of eNOS in the sinusoids of the newborn rat, eNOS offers protection in CCl 4 toxicity. Additionally, the protective effect of NO may be related to its anti-apoptosis activity and protection against cytokine mediated cell death (30) .
In this model of hepatotoxicity, eNOS activity was increased after exposure to CCl 4 , without changes in mRNA and protein levels. This increase in eNOS activity might be associated with the posttranslational modification of eNOS due to phosphorylation mediated by Akt, a down stream effector in the PI3 K/Akt signaling pathway. Previous studies have shown that Akt directly phosphorylates eNOS, activating it to produce NO both in transfected COS-7 cells and cultured endothelial cells (17) . Akt has no effect on iNOS or nNOS (17) , making any contribution of these forms of NOS unlikely in our model. Activation of Akt is dependent on the degree of shear force stress, with direct correlation between increased stress and increased Akt phosphorylation (18) . In the current study, treatment of newborn rats with CCl 4 resulted in increased phosphorylation of Akt and eNOS associated with increased eNOS activity. Administration of the PI3 K inhibitor wortmannin resulted in reduction of Akt and eNOS phosphorylation both in control and CCl 4 -treated animals. Coadministration of CCl 4 and wortmannin, led to a significant decrease in eNOS activity and increase in hepatic damage. Thus, posttranslational eNOS activation is responsible for increased eNOS activity following CCl 4 exposure.
In conclusion, we have confirmed that newborn animals exposed to CCl 4 have hepatic injury, which is associated with increased levels of eNOS activity. Co-administration of CCl 4 and L-NAME results in worsening of hepatic damage, suggesting a protective role for eNOS in this model. We propose that the protective effect of eNOS is accomplished by its activation through the posttranslational modification via PI3 K/Akt signaling pathway. 
